These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 3552280)

  • 21. Hypoxia as a biomarker for radioresistant cancer stem cells.
    Peitzsch C; Perrin R; Hill RP; Dubrovska A; Kurth I
    Int J Radiat Biol; 2014 Aug; 90(8):636-52. PubMed ID: 24844374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia.
    Blumenthal RD; Taylor A; Osorio L; Ochakovskaya R; Raleigh JA; Papadopoulou M; Bloomer WD; Goldenberg DM
    Int J Cancer; 2001 Nov; 94(4):564-71. PubMed ID: 11745445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxic radiosensitization: adored and ignored.
    Overgaard J
    J Clin Oncol; 2007 Sep; 25(26):4066-74. PubMed ID: 17827455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: x-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo.
    Leith JT; Quaranto L; Padfield G; Michelson S; Hercbergs A
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):283-7. PubMed ID: 8420876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines.
    Zölzer F; Streffer C
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):910-20. PubMed ID: 12377345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.
    Stone HB; Brown JM; Phillips TL; Sutherland RM
    Radiat Res; 1993 Dec; 136(3):422-34. PubMed ID: 8278585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of tumor oxygenation by mild hyperthermia.
    Song CW; Park H; Griffin RJ
    Radiat Res; 2001 Apr; 155(4):515-28. PubMed ID: 11260653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor oxygen measurements and personalized medicine.
    Okunieff P; O'Dell W; Zhang M; Zhang L; Maguire D
    Adv Exp Med Biol; 2013; 765():195-201. PubMed ID: 22879033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment.
    Busk M; Horsman MR
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):219-34. PubMed ID: 24045619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic advantage of hypoxic cells in tumors: a theoretical study.
    Brown JM; Koong A
    J Natl Cancer Inst; 1991 Feb; 83(3):178-85. PubMed ID: 1988703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
    Yang J; Li W; Luo L; Jiang M; Zhu C; Qin B; Yin H; Yuan X; Yin X; Zhang J; Luo Z; Du Y; You J
    Biomaterials; 2018 Nov; 182():145-156. PubMed ID: 30121013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours.
    Rofstad EK; Sutherland RM
    Br J Cancer; 1989 Jan; 59(1):28-35. PubMed ID: 2757922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting hypoxia cell signaling for cancer therapy.
    Melillo G
    Cancer Metastasis Rev; 2007 Jun; 26(2):341-52. PubMed ID: 17415529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine.
    Beck R; Röper B; Carlsen JM; Huisman MC; Lebschi JA; Andratschke N; Picchio M; Souvatzoglou M; Machulla HJ; Piert M
    J Nucl Med; 2007 Jun; 48(6):973-80. PubMed ID: 17536108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.
    Carlson DJ; Stewart RD; Semenenko VA
    Med Phys; 2006 Sep; 33(9):3105-15. PubMed ID: 17022202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical modifiers of cancer treatment.
    Coleman CN; Bump EA; Kramer RA
    J Clin Oncol; 1988 Apr; 6(4):709-33. PubMed ID: 3282035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radiation sensitizing agents for hypoxic cells: past, present and future].
    Lartigau E
    Cancer Radiother; 1998 Dec; 2(6):775-80. PubMed ID: 9922787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxic tumors and their effect on immune cells and cancer therapy.
    Yotnda P; Wu D; Swanson AM
    Methods Mol Biol; 2010; 651():1-29. PubMed ID: 20686957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.